| scholarly article | Q13442814 |
| P50 | author | Karin Milde-Langosch | Q38297224 |
| P2093 | author name string | Klaus Pantel | |
| Volkmar Müller | |||
| Heidi Schwarzenbach | |||
| Bettina Steinbach | |||
| P2860 | cites work | Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia | Q24539231 |
| Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells | Q24649539 | ||
| Prediction of mammalian microRNA targets | Q27860498 | ||
| Oncomirs - microRNAs with a role in cancer | Q27860773 | ||
| The diverse functions of microRNAs in animal development and disease | Q28266193 | ||
| mir-17-92, a cluster of miRNAs in the midst of the cancer network | Q28275929 | ||
| A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation | Q28280072 | ||
| Dicer is essential for mouse development | Q28511142 | ||
| Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma | Q29614238 | ||
| MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN | Q29616575 | ||
| Small non-coding RNAs in animal development | Q29616776 | ||
| MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression | Q33784804 | ||
| MicroRNAs MiR-17, MiR-20a, and MiR-106b act in concert to modulate E2F activity on cell cycle arrest during neuronal lineage differentiation of USSC. | Q33809305 | ||
| Cell-free nucleic acids as biomarkers in cancer patients | Q34184393 | ||
| Costimulation-dependent expression of microRNA-214 increases the ability of T cells to proliferate by targeting Pten. | Q34416068 | ||
| MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemia. | Q34836437 | ||
| Cancer micrometastases | Q34978121 | ||
| Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma | Q35108381 | ||
| Dissecting the metastatic cascade | Q35788115 | ||
| Understanding breast cancer risk -- where do we stand in 2005? | Q36077410 | ||
| Bringing molecular prognosis and prediction to the clinic. | Q36130358 | ||
| Resistance to Trastuzumab in Breast Cancer. | Q36318226 | ||
| A critical evaluation of loss of heterozygosity detected in tumor tissues, blood serum and bone marrow plasma from patients with breast cancer | Q36458751 | ||
| The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer | Q36745379 | ||
| PTEN, more than the AKT pathway | Q36753139 | ||
| Insights into minimal residual disease in cancer patients: implications for anti-cancer therapies | Q37720117 | ||
| Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer. | Q37877173 | ||
| Role of microRNA-214-targeting phosphatase and tensin homolog in advanced glycation end product-induced apoptosis delay in monocytes | Q39608598 | ||
| MicroRNA-dependent regulation of PTEN after arsenic trioxide treatment in bladder cancer cell line T24. | Q39653380 | ||
| Circulating microRNAs in plasma of patients with gastric cancers | Q39986294 | ||
| Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. | Q51535040 | ||
| Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. | Q53416418 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| P304 | page(s) | 933-941 | |
| P577 | publication date | 2012-02-19 | |
| P1433 | published in | Breast Cancer Research and Treatment | Q326085 |
| P1476 | title | Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients. | |
| P478 | volume | 134 |
| Q36251395 | A Five-miRNA Panel Identified From a Multicentric Case-control Study Serves as a Novel Diagnostic Tool for Ethnically Diverse Non-small-cell Lung Cancer Patients |
| Q40420399 | A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer |
| Q38060281 | An emerging role for microRNAs in NF1 tumorigenesis |
| Q35141171 | Analysis of miRNA expression profiles in breast cancer using biclustering |
| Q33751048 | Anticancer effect of curcumin inhibits cell growth through miR-21/PTEN/Akt pathway in breast cancer cell |
| Q34391443 | Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases |
| Q34426839 | Cell-free nucleic acids as non-invasive biomarkers of gynecological cancers, ovarian, endometrial and obstetric disorders and fetal aneuploidy |
| Q34221705 | Circulating miR-148b and miR-133a as biomarkers for breast cancer detection |
| Q33720085 | Circulating microRNA-214 and -126 as potential biomarkers for canine neoplastic disease |
| Q36546638 | Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer |
| Q42122645 | Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers. |
| Q28081347 | Circulating microRNAs: potential biomarkers for common malignancies |
| Q37690204 | Circulating nucleic acids as biomarkers in breast cancer |
| Q93109146 | Clinical Translatability of "Identified" Circulating miRNAs for Diagnosing Breast Cancer: Overview and Update |
| Q38184908 | Clinical relevance of circulating cell-free microRNAs in cancer |
| Q43699921 | Combined aberrant expression of microRNA-214 and UBC9 is an independent unfavorable prognostic factor for patients with gliomas |
| Q37195490 | Cross talk between miR-214 and PTEN attenuates glomerular hypertrophy under diabetic conditions |
| Q92917120 | Cross-Roads to Drug Resistance and Metastasis in Breast Cancer: miRNAs Regulatory Function and Biomarker Capability |
| Q51442271 | Crosstalk between the vitamin D receptor (VDR) and miR-214 in regulating SuFu, a hedgehog pathway inhibitor in breast cancer cells. |
| Q34614489 | Dampening enthusiasm for circulating microRNA in breast cancer |
| Q28069370 | Decoding the usefulness of non-coding RNAs as breast cancer markers |
| Q37551941 | Decreased expression of key tumour suppressor microRNAs is associated with lymph node metastases in triple negative breast cancer |
| Q91834787 | Diagnostic and Prognostic Potential of Serum Cell-Free microRNA-214 in Glioma |
| Q58799732 | Downregulated circulating microRNAs after surgery: potential noninvasive biomarkers for diagnosis and prognosis of early breast cancer |
| Q38874857 | Downregulation of urinary cell-free microRNA-214 as a diagnostic and prognostic biomarker in bladder cancer |
| Q42176783 | Elucidating the mechanism of miRNA-214 in the regulation of gingival carcinoma |
| Q89749656 | Emergence of Circulating MicroRNAs in Breast Cancer as Diagnostic and Therapeutic Efficacy Biomarkers |
| Q51344612 | Evaluation of reference genes for the analysis of serum miRNA in patients with prostate cancer, bladder cancer and renal cell carcinoma. |
| Q35010133 | Four microRNAs promote prostate cell proliferation with regulation of PTEN and its downstream signals in vitro |
| Q35402769 | Hemolysis-free plasma miR-214 as novel biomarker of gastric cancer and is correlated with distant metastasis |
| Q38056383 | Hide and seek: tell-tale signs of breast cancer lurking in the blood. |
| Q35105646 | High expression of miR-214 is associated with a worse disease-specific survival of the triple-negative breast cancer patients. |
| Q28539562 | Impact of ketamine on learning and memory function, neuronal apoptosis and its potential association with miR-214 and PTEN in adolescent rats |
| Q26772219 | Inflamma-miRs in Aging and Breast Cancer: Are They Reliable Players? |
| Q49831055 | Inhibition of ATG12-mediated autophagy by miR-214 enhances radiosensitivity in colorectal cancer |
| Q35203556 | Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring. |
| Q36370545 | MiR-214 increases the sensitivity of breast cancer cells to tamoxifen and fulvestrant through inhibition of autophagy |
| Q26775086 | MiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer |
| Q37297742 | MiRNAs which target CD3 subunits could be potential biomarkers for cancers |
| Q38905681 | MiRNAs-mediated cisplatin resistance in breast cancer |
| Q38731400 | MicroRNA-152 Targets Phosphatase and Tensin Homolog to Inhibit Apoptosis and Promote Cell Migration of Nasopharyngeal Carcinoma Cells |
| Q86846257 | MicroRNA-17 family as novel biomarkers for cancer diagnosis: a meta-analysis based on 19 articles |
| Q35221535 | MicroRNA-214 suppresses gluconeogenesis by targeting activating transcriptional factor 4 |
| Q36336233 | MicroRNA-214 suppresses the proliferation of human hepatocellular carcinoma cells by targeting E2F3. |
| Q92582088 | MicroRNA‑214 suppresses the viability, migration and invasion of human colorectal carcinoma cells via targeting transglutaminase 2 |
| Q89533287 | MicroRNA‑299‑5p inhibits cell metastasis in breast cancer by directly targeting serine/threonine kinase 39 |
| Q37564492 | Network-based identification of microRNAs as potential pharmacogenomic biomarkers for anticancer drugs |
| Q38885507 | Noncoding RNAs in Cancer Diagnosis |
| Q36935047 | Noncoding RNAs in breast cancer |
| Q35034340 | Regulation of cancer metastasis by cell-free miRNAs |
| Q91317495 | Ribonucleic-acid-biomarker candidates for early-phase group detection of common cancers |
| Q90465776 | Role of miR-214 in modulating proliferation and invasion of human colon cancer SW620 cells |
| Q47728281 | Role of micro-RNAs in breast cancer surgery. |
| Q37196131 | Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma |
| Q38886081 | Specific miRNA Disease Biomarkers in Blood, Serum and Plasma: Challenges and Prospects |
| Q92280511 | The Roles of miRNAs in Medulloblastoma: A Systematic Review |
| Q26825022 | The circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controversies of non-coding and coding RNA in body fluids |
| Q39097267 | The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs. |
| Q54243283 | Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma. |
| Q92755500 | Why the Gold Standard Approach by Mammography Demands Extension by Multiomics? Application of Liquid Biopsy miRNA Profiles to Breast Cancer Disease Management |
| Q27023833 | miR-214 as a key hub that controls cancer networks: small player, multiple functions |
| Q38319595 | miR-214: a potential biomarker and therapeutic for different cancers |
| Q38336073 | microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer |
| Q38197675 | microRNAs: a new class of breast cancer biomarkers. |
Search more.